SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification

Development

Volumn 137, Issue 6, 2010, Pages 901-911

  Hattori, Takako ^a   Müller, Catharina ^b   Gebhard, Sonja ^b   Bauer, Eva ^b   Pausch, Friederike ^b   Schlund, Britta ^b   Bösl, Michael R ^c   Hess, Andreas ^d   Surmann Schmitt, Cordula ^b   Von Der Mark, Helga ^b   De Crombrugghe, Benoit ^e   Von Der Mark, Klaus ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BAC; Collagen X; Mmp13; Mouse; Runx2; Transgenic; Vegfa

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD31 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGENASE 3; COMPLEMENTARY DNA; GENOMIC DNA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; SMALL INTERFERING RNA; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN A; SOX9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROLYSIS; CHROMATIN IMMUNOPRECIPITATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC TRANSFECTION; GROWTH PLATE; GROWTH RETARDATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSGENIC MOUSE; VASCULARIZATION; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL; ANIMAL EMBRYO; ARTICULAR CARTILAGE; BONE DEVELOPMENT; BONE MINERALIZATION; CARTILAGE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPERTROPHY; METABOLISM; ORGANOGENESIS; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MUS MUSCULUS;

ANIMALS; ANIMALS, NEWBORN; BONE MARROW; CALCIFICATION, PHYSIOLOGIC; CARTILAGE; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH PLATE; HYPERTROPHY; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGANOGENESIS; OSTEOGENESIS; SOX9 TRANSCRIPTION FACTOR;

EID: 77950345356     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.045203     Document Type: Article

References (59)

1. Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. and de Crombrugghe, B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813-2828.
2. Ballock, R. T. and O'Keefe, R. J. (2003). The biology of the growth plate. J. Bone Joint Surg. Am. 85, 715-726.
3. Bi, W., Huang, W., Whitworth, D. J., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (2001). Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. USA 98, 6698-6703.
4. Bitgood, M. J. and McMahon, A. P. (1995). Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172, 126-138.
5. Carlevaro, M. F., Cermelli, S., Cancedda, R. and Descalzi Cancedda, F. (2000). Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113, 59-69.
6. Day, T. F. and Yang, Y. (2008). Wnt and hedgehog signaling pathways in bone development. J. Bone Joint Surg. Am. 1, 19-24.
7. de Crombrugghe, B., Lefebvre, V. and Nakashima, K. (2001). Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol. 13, 721-727.
8. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
9. Eshkar-Oren, I., Vuikov, S. V., Salameh, S., Krief, S., Oh, C. D., Akiyama, H., Gerber, H. P., Ferrara, N. and Zelzer, E. (2009). The forming limb skeleton served as signalling center for limb vasculature patterning visa regulation of VEGF. Development 136, 1263-1272.
10. Franzen, A., Oldberg, A. and Solursh, M. (1989). Possible recruitment of osteoblastic precursor cells from hypertrophic chondrocytes during initial osteogenesis in cartilaginous limbs of young rats. Matrix 9, 261-265.
11. Gebhard, S., Hattori, T., Bauer, E., Bosl, M. R., Schlund, B., Poschl, E., Adam, N., de Crombrugghe, B. and von der Mark, K. (2007). BAC constructs in transgenic reporter mouse lines control efficient and specific LacZ expression in hypertrophic chondrocytes under the complete Col10a1 promoter. Histochem. Cell Biol. 127, 183-194.
12. Gebhard, S., Hattori, T., Bauer, E., Schlund, B., Bosl, M. R., de Crombrugghe, B. and von der Mark, K. (2008). Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter. Matrix Biol. 27, 693-699.
13. Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z. and Ferrara, N. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623-628.
14. Goldring, M. B., Tsuchimochi, K. and Ijiri, K. (2006). The control of chondrogenesis. J. Cell. Biochem. 97, 33-44.
15. Hartmann, C. (2007). Skeletal development-Wnts are in control. Mol. Cells 24, 177-184.
16. Hattori, T., Eberspaecher, H., Lu, J., Zhang, R., Nishida, T., Kahyo, T., Yasuda, H. and de Crombrugghe, B. (2006). Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J. Biol. Chem. 281, 14417-14428.
17. Hattori, T., Coustry, F., Stephens, S., Eberspaecher, H., Takigawa, M., Yasuda, H. and de Crombrugghe, B. (2008). Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res. 36, 3011-3024.
18. Hess, J., Porte, D., Munz, C. and Angel, P. (2001). AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem. 276, 20029-20038.
19. Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., Sato, M., Yamagiwa, H., Kimura, T., Yasui, N. et al. (1999). Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214, 279-290.
20. Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., Lopez-Otin, C. and Krane, S. M. (2004). Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA 101, 17192-17197.
21. Jimenez, M. J., Balbin, M., Lopez, J. M., Alvarez, J., Komori, T. and Lopez-Otin, C. (1999). Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol. Cell. Biol. 19, 4431-4442.
22. Johansson, N., Saarialho-Kere, U., Airola, K., Herva, R., Nissinen, L., Westermarck, J., Vuorio, E., Heino, J. and Kahari, V. M. (1997). Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208, 387-397.
23. Kim, I. S., Otto, F., Zabel, B. and Mundlos, S. (1999). Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159-170.
24. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
25. Kronenberg, H. M. (2006). PTHrP and skeletal development. Ann. New York Acad. Sci. 1068, 1-13.
26. Lanske, B., Karaplis, A. C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L. H. K., Ho, C., Mulligan, R. C. et al. (1996). PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273, 663-666.
27. Lee, E. C., Yu, D., Martinez de Velasco, J., Tessarollo, L., Swing, D. A., Court, D. L., Jenkins, N. A. and Copeland, N. G. (2001). A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73, 56-65.
28. Lefebvre, V. and de Crombrugghe, B. (1998). Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol. 16, 529-540.
29. Lefebvre, V. and Smits, P. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C Embryo Today 75, 200-212.
30. Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. and de Crombrugghe, B. (1997). SOX9 is a potent activator of the chondrocytespecific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346.
31. Maes, C., Stockmans, I., Moermans, K., Van Looveren, R., Smets, N., Carmeliet, P., Bouillon, R. and Carmeliet, G. (2004). Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113, 188-199.
32. Mori, K., Kitazawa, R., Kondo, T., Maeda, S., Yamaguchi, A. and Kitazawa, S. (2006). Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. J. Cell. Biochem. 98, 1629-1644.
33. Ng, L. J., Wheatley, S., Muscat, G. E., Conway-Campbell, J., Bowles, J., Wright, E., Bell, D. M., Tam, P. P., Cheah, K. S. and Koopman, P. (1997). SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108-121.
34. Nishida, T., Kondo, S., Maeda, A., Kubota, S., Lyons, K. M. and Takigawa, M. (2009). CCN family 2/connective tissue growth factor (CCN2/CTGF) regulates the expression of Vegf through Hif-1alpha expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition. Bone 44, 24-31.
35. Olsen, B. R., Reginato, A. M. and Wang, W. (2000). Bone development. Annu. Rev. Cell Dev. Biol. 16, 191-220.
36. Ortega, N., Behonick, D. J. and Werb, Z. (2004). Matrix remodeling during endochondral ossification. Trends Cell Biol. 14, 86-93.
37. Porte, D., Tuckermann, J., Becker, M., Baumann, B., Teurich, S., Higgins, T., Owen, M. J., Schorpp-Kistner, M. and Angel, P. (1999). Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18, 667-678.
38. Provot, S. and Schipani, E. (2005). Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun. 328, 658-665.
39. Reponen, P., Leivo, I., Sahlberg, C., Apte, S. S., Olsen, B. R., Thesleff, I. and Tryggvason, K. (1995). 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev. Dyn. 202, 388-396.
40. Schipani, E., Ryan, H. E., Didrickson, S., Kobayashi, T., Knight, M. and Johnson, R. S. (2001). Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865-2876.
41. Schmidl, M., Adam, N., Surmann-Schmitt, C., Hattori, T., Stock, M., Dietz, U., Decrombrugghe, B., Poschl, E. and von der Mark, K. C. (2006). Twisted gastrulation modulates BMP- induced collagen II and X expression in chondrocytes in vitro and in vivo. J. Biol. Chem. 281, 31790-31800.
42. Selvamurugan, N., Kwok, S. and Partridge, N. C. (2004). Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J. Biol. Chem. 279, 27764-27773.
43. Shukunami, C. and Hiraki, Y. (2001). Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation. Osteoarthritis Cartilage 9, S91-S101.
44. Stickens, D., Behonick, D. J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A. J., Schorpp-Kistner, M., Angel, P. and Werb, Z. (2004). Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131, 5883-5895.
45. Stricker, S., Fundele, R., Vortkamp, A. and Mundlos, S. (2002). Role of Runx genes in chondrocyte differentiation. Dev. Biol. 245, 95-108.
46. Surmann-Schmitt, C., Dietz, U., Kireva, T., Adam, N., Park, J., Tagariello, A., Onnerfjord, P., Heinegard, D., Schlotzer-Schrehardt, U., Deutzmann, R. et al. (2008). Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis. J. Biol. Chem. 283, 7082-7093.
47. Takeda, S., Bonnamy, J. P., Owen, M. J., Ducy, P. and Karsenty, G. (2001). Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467-481.
48. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
49. Usui, M., Xing, L., Drissi, H., Zuscik, M., O'Keefe, R., Chen, D. and Boyce, B. F. (2008). Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J. Bone Miner Res. 23, 314-325.
50. Vortkamp, A., Lee, K., Lanske, B., Segre, G. V., Kronenberg, H. M. and Tabin, C. J. (1996). Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273, 613-622.
51. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
52. Wang, X., Manner, P. A., Horner, A., Shum, L., Tuan, R. S. and Nuckolls, G. H. (2004). Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 12, 963-973.
53. Wilsman, N. J., Bernardini, E. S., Leiferman, E., Noonan, K. and Farnum, C. E. (2008). Age and pattern of the onset of differential growth among growth plates in rats. J. Orthop. Res. 26, 1457-1465.
54. Yamagiwa, H., Tokunaga, K., Hayami, T., Hatano, H., Uchida, M., Endo, N. and Takahashi, H. E. (1999). Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. Bone 25, 197-203.
55. Zelzer, E., Glotzer, D. J., Hartmann, C., Thomas, D., Fukai, N., Soker, S. and Olsen, B. R. (2001). Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106, 97-106.
56. Zelzer, E., McLean, W., Ng, Y. S., Fukai, N., Reginato, A. M., Lovejoy, S., D'Amore, P. A. and Olsen, B. R. (2002). Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904.
57. Zelzer, E., Mamluk, R., Ferrara, N., Johnson, R. S., Schipani, E. and Olsen, B. R. (2004). VEGFA is necessary for chondrocyte survival during bone development. Development 131, 2161-2171.
58. Zhao, Q., Eberspaecher, H., Lefebvre, V. and de Crombrugghe, B. (1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209, 377-386.
59. Zhou, G., Zheng, Q., Engin, F., Munivez, E., Chen, Y., Sebald, E., Krakow, D. and Lee, B. (2006). Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. USA 103, 19004-19009.